Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atracurium-vecuronium combination in laparoscopic surgery
NCT03371953Phase 4Unknown
- Sponsor
- Sir Ganga Ram Hospital
- Start
- Dec 2017
- Primary completion
- Oct 2018
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of atracurium and vecuronium (3 arms), sponsored by Sir Ganga Ram Hospital. Primary endpoint: Duration-of-action of the intubating dose at 60 months. Status: unknown.
02
Drugs
atracuriumvecuronium
Beyond the preview
Go deeper on NCT03371953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03371953.